Skip Navigation

Diversion Quarterly Q2 2022

Diversion Quarterly Q2 2022

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of June 30th, 2022. Data was pulled from health systems across the United States.

Key Takeaways

• Across the last quarter, the percentage of cases with variances has decreased. This can be explained due to both hospitals improving documentation compliance, as well as Bluesight for Controlled Substances improving its ability to identify true discrepancies.

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?